Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400087440Phase 4Not yet recruiting
Phase 4, randomised trial of esketamine in laryngeal polyp (3 arms), sponsored by The Second Xiangya Hospital. Primary endpoints: heart rate and mean arterial pressure. Planned start Jul 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400087440.